New-onset hepatitis C virus-associated glomerulonephritis following sustained virologic response with direct-acting antiviral therapy

Clinical Nephrology

Volumn 87, Issue 5, 2017, Pages 261-266

  Ghosn, Muriel ^a   Palmer, Matthew B ^a   Najem, Catherine E ^a   Haddad, Danny ^b   Merkel, Peter A ^a   Hogan, Jonathan J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Robert Wood Johnson Barnabas Health   (United States)

Author keywords

Direct acting antiviral therapy; Glomerulonephritis; Hepatitis C; Mixed cryoglobulinemia

Indexed keywords

ALBUMIN; ANTIVIRUS AGENT; C REACTIVE PROTEIN; CREATININE; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTERASE; HEME; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PEGINTERFERON ALPHA; PREDNISONE; PROTEIN; RHEUMATOID FACTOR; RIBAVIRIN; RITUXIMAB; SIMEPREVIR; SOFOSBUVIR; VINCRISTINE;

ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIARRHEA; DIRECT ACTING ANTIVIRAL THERAPY; ELECTRON MICROSCOPY; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GLOMERULONEPHRITIS; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; LYMPHOCYTIC INFILTRATION; MEDICAL HISTORY; NAUSEA; NEUTROPHIL CHEMOTAXIS; NONHODGKIN LYMPHOMA; PLASMA EXCHANGE; PROTEIN ELECTROPHORESIS; PROTEIN URINE LEVEL; QUALITATIVE ANALYSIS; RASH; REMISSION; SKIN BIOPSY; SUSTAINED VIROLOGIC RESPONSE; TREATMENT DURATION; URINALYSIS; URTICARIA; VASCULITIS; VERY ELDERLY; VOMITING; YOUNG ADULT; COMPLICATION; VIROLOGY;

ADULT; AGED, 80 AND OVER; ANTIVIRAL AGENTS; FEMALE; GLOMERULONEPHRITIS; HEPATITIS C; HUMANS; SUSTAINED VIROLOGIC RESPONSE;

EID: 85017520730     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN109019     Document Type: Article

References (24)

1. Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am J Kidney Dis. 2013; 61: 623-637
2. Cacoub P, Comarmond C, Domont F, Savey L, Saadoun D. Cryoglobulinemia Vasculitis. Am J Med. 2015; 128: 950-955
3. Levine JW, Gota C, Fessler BJ, Calabrese LH, Cooper SM. Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol. 2005; 32: 1164-1167
4. Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, Cacoub P. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum. 2008; 58: 604-611
5. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis. 2003; 42: 631-657
6. Vassilopoulos D, Calabrese LH. Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum. 2002; 46: 585-597
7. Zignego AL, Giannini C, Gragnani L. HCV and lymphoproliferation. Clin Dev Immunol. 2012; 2012: 980942
8. Kondo Y, Shimosegawa T. Direct effects of hepatitis C virus on the lymphoid cells. World J Gastroenterol. 2013; 19: 7889-7895
9. Charles ED, Dustin LB. Hepatitis C virus-induced cryoglobulinemia. Kidney Int. 2009; 76: 818-824
10. Musto P. Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple association. Clin Lymphoma. 2002; 3: 150-160
11. Ara AK, Paul JP. New Direct-Acting Antiviral Therapies for Treatment of Chronic Hepatitis C Virus Infection. Gastroenterol Hepatol (N Y). 2015; 11: 458-466
12. Cornella SL, Stine JG, Kelly V, Caldwell SH, Shah NL. Persistence of mixed cryoglobulinemia despite cure of hepatitis C with new oral antiviral therapy including direct-acting antiviral sofosbuvir: A case series. Postgrad Med. 2015; 127: 413-417
13. Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, Steele D, Thiim M, Williams WW, Hashemi N, Kim AY, Thadhani R, Chung RT. Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology. 2016; 63: 408-417
14. Pham TN, MacParland SA, Mulrooney PM, Cooksley H, Naoumov NV, Michalak TI. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol. 2004; 78: 5867-5874
15. Gullett JC, Nolte FS. Quantitative nucleic acid amplification methods for viral infections. Clin Chem. 2015; 61: 72-78
16. Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, Huraux JM, Piette JC, Godeau P. Mixed cryoglobulinemia and hepatitis C virus. Am J Med. 1994; 96: 124-132
17. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992; 327: 1490-1495
18. Van Thiel DH, Fagiuoli S, Caraceni P, Wright HI, Nadir A, Gavaler JS, Zuhdi N. Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J Hepatol. 1995; 22: 464-467
19. Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum. 1997; 40: 2007-2015
20. Muratori L, Gibellini D, Lenzi M, Cataleta M, Muratori P, Morelli MC, Bianchi FB. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptasepolymerase chain reaction. Blood. 1996; 88: 2768-2774
21. Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology. 2005; 41: 106-114
22. Goutagny N, Fatmi A, De Ledinghen V, Penin F, Couzigou P, Inchauspé G, Bain C. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis. 2003; 187: 1951-1958
23. Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, Besson C, Varet B, Troussard X, Cacoub P, Hermine O. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood. 2005; 105: 74-76
24. Sise M, Wisocky J, Rosales Y, et al. Lupus-like immune complex-mediated glomerulonephritis in patients with hepatitis C virus infection treated with oral, interferon-free, direct-acting antiviral therapy. KI Rep. 2016; 1: 135-143